Ectopic expression of the human adenine nucleotide translocase, isoform 3 (ANT-3). Characterization of ligand binding properties

• DOI: 10.1016/j.mito.2004.06.004
• Publication Date: 2004-10-21T18:49:05Z
• Authors: A.K. Carroll; W.R. Clevenger; T. Szabo; L.E. Ackermann; Y. Pei; S.S. Ghosh; S. Glasco; R. Nazarbaghi; R.E. Davis; C.M. Anderson
• Keywords: 0303 health sciences; Gene Expression; Atractyloside; In Vitro Techniques; Moths; Ligands; Adenine Nucleotide Translocator 3; Mitochondria, Heart; Recombinant Proteins; Cell Line; 3. Good health; Adenosine Diphosphate; Iodine Radioisotopes; Mitochondrial Proteins; Kinetics; 03 medical and health sciences; Animals; Humans; Cattle; Bongkrekic Acid; Energy Metabolism; Protein Binding

The adenine nucleotide translocase (ANT) is a key component in maintaining cellular energy homeostasis, and has also been implicated in formation of the mitochondrial permeability transition pore. Human ANT-3 was cloned from a human heart cDNA library and expressed as a histidine-tagged fusion protein in the mitochondria of the Trichoplusia ni. cell line. Overexpression resulted in a concomitant decrease in the endogenous ANT content, allowing for the characterization of binding of known ANT ligands to the human protein. Binding affinities for bongkrekic acid (BKA), ADP, and atractyloside (ATR) were measured in mitochondria from the human ANT-3 expressing cell line, and compared to similar preparations from bovine heart mitochondria by use of a novel radioiodinated derivative of ATR. Binding to ANT-3 by the high affinity inhibitors BKA and ATR, as well as the lower affinity natural ligand ADP, was similar to that measured in bovine heart mitochondria, and to that previously reported for mammalian heart mitochondria. Characterizations such as these of human ANT isoforms may lead to drug development for enhanced mitochondrial function and cellular viability.